Solta Medical Inc. (NSDQ:SLTM) received Food & Drug Administration clearance for its Fraxel re:store dual laser system for skin resurfacing.
The Hayward, Calif.-based cosmetic laser surgery developer said the device treats actinic keratosis, a pre-malignant skin growth caused by sun damage.